Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPT
826
DELISTED
Liberty Property Trust
LPT
| $13M | 0.02% |
402,510
-577,386
| -59% | -$20.1M |
|
|
DBD
827
DELISTED
Diebold Nixdorf Incorporated
DBD
| $12.9M | 0.02% |
369,664
-238,046
| -39% | -$8.4M |
|
|
MEG
828
DELISTED
Media General, Inc
MEG
| $12.9M | 0.02% |
782,463
-851,642
| -52% | -$14.2M |
|
|
SLH
829
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $12.9M | 0.02% |
290,077
+123,481
| +74% | +$6.08M |
|
830
Interface
TILE
$2.21B
| $12.9M | 0.02% |
515,840
-15,136
| -3% | -$335K |
|
831
CALL
Alkermes
ALKS
$8.2B
| $12.9M | 0.02% |
+200,000
| New | +$12.2M |
|
|
TTM
832
DELISTED
Tata Motors Limited
TTM
| $12.8M | 0.02% |
372,259
+8,099
| +2% | +$323K |
|
|
BRFS
833
DELISTED
BRF SA
BRFS
| $12.8M | 0.02% |
612,890
-607,701
| -50% | -$12.8M |
|
|
BCR
834
CALL
DELISTED
CR Bard Inc.
BCR
| $12.8M | 0.02% |
75,000
+73,200
| +4,067% | +$12.5M |
|
835
Ambev
ABEV
$45B
| $12.8M | 0.02% |
2,097,020
+1,680,534
| +404% | +$10.4M |
|
836
Cirrus Logic
CRUS
$5.6B
| $12.8M | 0.02% |
375,267
+343,727
| +1,090% | +$12.1M |
|
837
Bruker
BRKR
$8.68B
| $12.8M | 0.02% |
624,775
-1,700,826
| -73% | -$34.4M |
|
|
FNHC
838
DELISTED
FedNat Holding Company Common Stock
FNHC
| $12.7M | 0.02% |
524,517
+320,579
| +157% | +$8.7M |
|
|
INFA
839
DELISTED
INFORMATICA CORP
INFA
| $12.6M | 0.02% |
260,600
-1,299,192
| -83% | -$62.5M |
|
840
Integra LifeSciences
IART
$1.3B
| $12.6M | 0.02% |
+458,236
| New | +$12.2M |
|
841
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $12.6M | 0.02% |
157,035
-67,938
| -30% | -$5.45M |
|
842
Red Robin
RRGB
$191M
| $12.6M | 0.02% |
+146,549
| New | +$12.1M |
|
|
STJ
843
DELISTED
St Jude Medical
STJ
| $12.6M | 0.02% |
172,002
-405,066
| -70% | -$29.3M |
|
|
FMSA
844
PUT
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $12.6M | 0.02% |
1,534,300
+1,116,400
| +267% | +$9.58M |
|
|
SUM
845
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $12.5M | 0.02% |
519,912
-550,233
| -51% | -$13.1M |
|
846
LG Display
LPL
$3.29B
| $12.5M | 0.02% |
1,079,807
+651,139
| +152% | +$8.78M |
|
|
BDSI
847
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $12.5M | 0.02% |
1,571,200
-291,392
| -16% | -$2.5M |
|
848
ProQR Therapeutics
PRQR
$343M
| $12.5M | 0.02% |
748,533
+15,351
| +2% | +$289K |
|
|
DENN
849
DELISTED
Denny's
DENN
| $12.5M | 0.02% |
1,073,184
+113,734
| +12% | +$1.27M |
|
850
Diamondrock Hospitality Co
DRH
$2.61B
| $12.4M | 0.02% |
969,646
-577,346
| -37% | -$7.79M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.